Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N H Walde

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 20, 1982
[Chloroquine resistant falciparum malaria in East Africa illustrated by a case of cerebral malaria]N H Walde, B Bjorvatn
Hepato-Gastroenterology|December 1, 1981
The effect of secretin in physiological doses on serum group I pepsinogens (PG I) in manN H Walde, H L Waldum
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 10, 1985
[Lymphomatoid granulomatosis]N H Walde, A Gulsvik, A Myking
Journal of Cardiovascular Pharmacology|February 1, 1987
Improved cardiac performance by salbutamol, a selective beta 2-agonist, in chronic cor pulmonaleH Vik-Mo, F J Halvorsen, E Thorsen, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 20, 1982
[Chloroquine resistant falciparum malaria in East Africa illustrated by a case of cerebral malaria]N H Walde, B Bjorvatn
Hepato-Gastroenterology|December 1, 1981
The effect of secretin in physiological doses on serum group I pepsinogens (PG I) in manN H Walde, H L Waldum
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 10, 1985
[Lymphomatoid granulomatosis]N H Walde, A Gulsvik, A Myking
Journal of Cardiovascular Pharmacology|February 1, 1987
Improved cardiac performance by salbutamol, a selective beta 2-agonist, in chronic cor pulmonaleH Vik-Mo, F J Halvorsen, E Thorsen, et al.
Pageof 1